Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the...

Fujitsu awarded contract to design next-generation flagship supercomputer FugakuNEXT

Fujitsu awarded contract to design next-generation flagship supercomputer FugakuNEXT

Accelerating scientific and technological innovation with Made-in-Japan CPU technology KAWASAKI, Japan, June 18, 2025 /PRNewswire/ -- Fujitsu Limited today announced that it has been awarded a contract by the Japanese research and development...

US, UK, and Congolese officials inaugurate Kiswishi City Special Economic Zone

US, UK, and Congolese officials inaugurate Kiswishi City Special Economic Zone

KISWISHI CITY, Democratic Republic of Congo, June 16, 2025 /PRNewswire/ -- American, British, and Congolese government officials launched major foreign direct investments in the Democratic Republic of the Congo (DRC) with the groundbreaking of a USD...

From Campus to Cockpit: Chula-Thai Airways Unite for a Future-Ready Thailand

From Campus to Cockpit: Chula-Thai Airways Unite for a Future-Ready Thailand

BANGKOK, June 16, 2025 /PRNewswire/ -- Chulalongkorn University and Thai Airways International Public Company Limited have signed a memorandum of understanding (MoU) to promote and develop educational potential and knowledge exchange to create value...

LexisNexis to Launch Enhanced Lexis+ AI in Hong Kong - First in APAC with Built-In LexisNexis Protégé using both generative and agentic AI

LexisNexis to Launch Enhanced Lexis+ AI in Hong Kong - First in APAC with Built-In LexisNexis Protégé using both generative and agentic AI

Developed with customers leading the next wave of legal AI innovation , Lexis+ AI™ with Protege™ delivers personalised AI assistance to drive next-level productivity and outcomes. HONG KONG, June 13, 2025 /PRNewswire/ -- LexisNexis® Legal &...

MIPS and Cyient Semiconductor collaborate to bring Custom RISC-V-based intelligent power solutions to AI Power Delivery, Industrial Robotics, and Automotive

MIPS and Cyient Semiconductor collaborate to bring Custom RISC-V-based intelligent power solutions to AI Power Delivery, Industrial Robotics, and Automotive

SAN JOSE, Calif. and HYDERABAD, India, June 12, 2025 /PRNewswire/ -- Cyient Semiconductors Private Limited, a fast-growing custom silicon company based in Hyderabad, and MIPS, a global leader in RISC-V processor IP, today announced a strategic...

Coaching seen as key priority for the future workplace, yet more than half of business leaders lack the formal training

Coaching seen as key priority for the future workplace, yet more than half of business leaders lack the formal training

Coaching (34%) emerges as one of the top initiatives business leaders foresee their organisation prioritising in the next five years. Majority of business leaders (94%) and employees (92%) believe that coaching benefits individuals across all levels...

Invitation for Interest to Participate for Development of the HKSTP San Tin Technopole

Invitation for Interest to Participate for Development of the HKSTP San Tin Technopole

HONG KONG, June 11, 2025 /PRNewswire/ -- CBRE has been appointed by Hong Kong Science and Technology Parks Corporation (HKSTP) as the lead consultant for the business, operation and investment models of the HKSTP San Tin Technopole (working title)....

Elpis Biopharmaceuticals and Singapore General Hospital Enter Research Collaboration Agreement to Develop Next Generation Allogeneic CAR Technologies

Elpis Biopharmaceuticals and Singapore General Hospital Enter Research Collaboration Agreement to Develop Next Generation Allogeneic CAR Technologies

Agreement focuses on advancing armored and bi-specific CAR-γδTs for AML and multiple myeloma LEXINGTON, Mass. and SINGAPORE, June 4, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored...

Singapore Unveils Insights from World's First Technical Testing of Real World Applications of GenAI

Singapore Unveils Insights from World's First Technical Testing of Real World Applications of GenAI

First Global AI Assurance Pilot brought global testing companies and GenAI deployers to test real world uses World's first Starter Kit for Gen AI applications to provide practical guidance to industry AI Singapore and the UN Development Programme to...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 13
  • menu
    menu